Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SWHFX vs. ETHSX: which is better?

Bottom line

SWHFX vs ETHSX: the short answer

SWHFX (Schwab Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 69% by weight.

SWHFX is cheaper at 0.8% vs 1.18% — a difference of $38 a year per $10,000 invested.

Over five years, SWHFX returned +6.5% a year vs +5.3% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

SWHFX vs ETHSX side by side

SWHFXETHSX
TypeMutual fundMutual fund
Fund familySchwabMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.8%1.18%
Annual cost per $10k$80$118
10-yr cost on $10k (prospectus)$990$1,911
Max front load—5.25%
12b-1 fee0%0.25%
1-yr return+15.9%−1.9%
5-yr return (annualized)+6.5%+5.3%
10-yr return (annualized)+8.1%+6.4%
Best quarter+15.3%+14.2%
Worst quarter−12.1%−12.1%
Net assets (fund)$642.3M$757.9M
Number of holdings8042
Portfolio turnover41%3%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSWHFXETHSXDifference
2024+0.1%+3.5%−3.4%
2023+0.7%+5.7%−5.0%
2022−4.7%−9.4%+4.8%
2021+23.3%+22.1%+1.2%
2020+12.9%+13.0%−0.2%
2019+17.6%+26.0%−8.4%
2018+4.0%+6.0%−2.0%
2017+20.2%+16.2%+4.0%
2016−4.4%−14.9%+10.5%

Source: Fund prospectus bar charts

Holdings overlap

16 of SWHFX's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingSWHFXETHSX
Eli Lilly & Co13.92%12.47%
Johnson & Johnson6.94%6.45%
AbbVie Inc5.81%6.46%
Merck & Co Inc4.98%5.08%
UnitedHealth Group Inc4.74%5.49%
Gilead Sciences Inc3.24%3.34%
Novartis AG2.92%1.65%
Bristol-Myers Squibb Co2.44%4.25%
Medtronic PLC2.29%1.80%
Roche Holding AG2.29%5.44%
Thermo Fisher Scientific Inc2.16%2.79%
Stryker Corp2.11%2.21%
Vertex Pharmaceuticals Inc1.89%3.38%
Boston Scientific Corp1.60%2.18%
Abbott Laboratories1.60%1.65%

Source: SEC Form N-PORT

SWHFX top 10

  1. Eli Lilly & Co — 13.92%
  2. Johnson & Johnson — 6.94%
  3. AbbVie Inc — 5.81%
  4. Merck & Co Inc — 4.98%
  5. UnitedHealth Group Inc — 4.74%
  6. Gilead Sciences Inc — 3.24%
  7. Novartis AG — 2.92%
  8. Amgen Inc — 2.58%
  9. Bristol-Myers Squibb Co — 2.44%
  10. Medtronic PLC — 2.29%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between SWHFX and ETHSX?
SWHFX (Schwab Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 69% by weight. SWHFX is cheaper at 0.8% vs 1.18% — a difference of $38 a year per $10,000 invested.
Which is cheaper, SWHFX or ETHSX?
SWHFX has the lower expense ratio (0.8%).
Should I own both SWHFX and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.